Increased retinol-binding protein (RBP) 4 and anti-RBP4 antibody in alopecia areata

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 837-844

  Ahn, K J ^a   Choi, E A ^b   Kim, J ^b   Lee, J H ^b   Lee, K H ^b   Bang, D ^b   Cho, S B ^b  

^a Hallym University   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; RETINOIC ACID; RETINOL BINDING PROTEIN 4; RETINOL BINDING PROTEIN 4 ANTIBODY; UNCLASSIFIED DRUG;

ALOPECIA AREATA; AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAIR DISEASE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIQUID CHROMATOGRAPHY; MALE PATTERN HAIR LOSS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEOMICS; SKIN BIOPSY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ALOPECIA AREATA; BIOLOGICAL MARKERS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; RETINOL-BINDING PROTEINS, PLASMA; UP-REGULATION;

EID: 80053511560     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10482.x     Document Type: Article

References (29)

1. Paus R, Slominski A, Czarnetzki BM,. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993; 66: 541-54.
2. McDonagh AJ, Tazi-Ahnini R,. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002; 27: 405-9.
3. Lu W, Shapiro J, Yu M, et al. Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006; 8: 1-19. (Pubitemid 43923144)
4. Barahmani N, Schabath MB, Duvic M,. National Alopecia Areta Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009; 61: 581-91.
5. Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-88.
6. Petukhova L, Duvic M, Hordinsky M, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010; 466: 113-17.
7. Hamm H, Klemmer S, Kreuzer I, et al. HLA-DR and HLA-DQ antigen expression of anagen and telogen hair bulbs in long-standing alopecia areata. Arch Dermatol Res 1998; 280: 179-81.
8. Paus R, Ito N, Takigawa M, Ito T,. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003; 8: 188-94. (Pubitemid 37222828)
9. Tobin DJ,. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 2003; 8: 176-81. (Pubitemid 37222826)
10. Leung MC, Sutton CW, Fenton DA, et al. Trichohyalin is a potential major autoantigen in human alopecia areata. J Proteome Res 2010; 9: 5153-63.
11. Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence database using mass spectrometry data. Electrophoresis 1999; 20: 3551-67. (Pubitemid 30007252)
12. Doustjalali SR, Yusof R, Yip CH, et al. Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 2004; 25: 2392-401. (Pubitemid 39136360)
13. Doustjalali SR, Yusof R, Govindasamy GK, et al. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. J Med Invest 2006; 53: 20-8.
14. Heukeshoven J, Dernick R,. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 1988; 9: 28-32.
15. Shevchenko A, Wilm M, Vorm O, Mann M,. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-8.
16. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-62. (Pubitemid 41065039)
17. Bobbert P, Weithäuser A, Andres J, et al. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur J Heart Fail 2009; 11: 1163-8.
18. Balagopal P, Graham TE, Kahn BB, et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007; 92: 1971-4. (Pubitemid 46997219)
19. Sell H, Eckel J,. Regulation of retinol binding protein 4 production in primary human adipocytes by adiponectin, troglitazone and TNF-alpha. Diabetologia 2007; 50: 2221-3. (Pubitemid 47373848)
20. Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007; 92: 2590-7. (Pubitemid 47037362)
21. Langouche L, Vander Perre S, Frystyk J, et al. Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care 2009; 13: R112.
22. Vaisbuch E, Romero R, Mazaki-Tovi S, et al. Retinol binding protein 4-a novel association with early-onset preeclampsia. J Perinat Med 2010; 38: 129-39.
23. Everts HB, Sundberg JP, King LE Jr, Ong DE,. Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle. J Invest Dermatol 2007; 127: 1593-604. (Pubitemid 46933403)
24. Napoli JL,. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1999; 1440: 139-62. (Pubitemid 29424180)
25. Duvic M, Martin AG, Kim Y, et al. Phase 2-3 clinical trial of oral Targretin (bexarotene) capsules for the treatment of refractory or persistent early stage cutaneous T-cell lymphoma. Arch Dermatol 2001; 137: 581-93. (Pubitemid 32458440)
26. Zhang C, Hazarika P, Ni X, et al. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma (CTCL) cells: relevance to mechanism of therapeutic action. Clin Cancer Res 2002; 8: 1234-40. (Pubitemid 34517663)
27. Talpur R, Vu J, Bassett R, et al. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol 2009; 61: 592.e1-9.
28. Gaetani S, Bellovino D, Apreda M, et al. Hepatic synthesis, maturation and complex formation between retinol-binding protein and transthyretin. Clin Chem Lab Med 2002; 40: 1211-20. (Pubitemid 36024658)
29. Adly MA,. Analysis of the expression pattern of the carrier protein transthyretin and its receptor megalin in the human scalp skin and hair follicles: hair cycle-associated changes. Histochem Cell Biol 2010; 134: 591-602.